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in adult airway epithelial cells
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Abstract
Bone morphogenetic proteins (BMPs) are critical morphogens and play key roles in epithelial–mesenchymal transitions
(EMTs) during embryogenesis. BMP4 is required for early mesoderm formation and also regulates morphogenesis and
epithelial cell differentiation in developing lungs. While, BMP signalling pathways are activated during lung inflammation in
adult mice, the role of BMPs in adult lungs remains unclear. We hypothesised that BMPs are involved in remodelling processes
in adult lungs and investigated effects of BMP4 on airway epithelial cells. BEAS-2B cell growth decreased in the presence of
BMP4. Cells acquired a mesenchymal-like morphology with downregulation of adherens junction proteins and increased cell
motility. Changes in extracellular matrix-related gene expression occurred with BMP4 treatment including upregulation of
collagens, fibronectin and tenascin C. We conclude that the activity of BMP4 in EMT during development is recapitulated in
adult airway epithelial cells and suggest that this activity may contribute to inflammation and fibrosis in vivo.
Keywords: BMP, EMT, ECM, E-cadherin, airway
Introduction
Epithelial and mesenchymal cells represent distinct cell
lineages with characteristic gene expression profiles
that confer specific features to each tissue type.
Respective characteristic profiles of cell adhesion and
cytoskeletal proteins enable epithelial cells to form
tightly connected, organised sheets while mesenchymal
cells are capable of motility and invasion. Epithelial–
mesenchyme transition (EMT) is a process whereby
epithelial cells lose their epithelial features and acquire
mesenchymal characteristics (Lee et al. 2006) and
occurs during morphogenesis (Shook and Keller
2003) and also during carcinogenesis and fibrosis in
adult tissues (Thiery 2003). During EMT, epithelial
cells alter their phenotype, downregulating expression
of specific cell adhesion molecules and cytokeratins
and inducing expression of mesenchymal-specific
proteins such as collagens, fibronectin, a-smooth
muscle actin and matrix degrading enzymes (Kalluri
and Neilson 2003). Altered protein expression is
accompanied by a switch in morphology as cells
acquire a mesenchymal-like appearance and grow in a
more scattered manner.
Induction of EMT occurs in response to cytokines
such as transforming growth factor beta 1 (TGF-b1),
fibroblast growth factor 2 (FGF-2), hepatocyte
growth factor (HGF) and epidermal growth factor
(EGF) (Savanger 2001). TGF-b1 in particular is
considered to be a prototypic inducer of EMT and
regulates this process both during development and in
adult disease states (Zavadil and Bottinger 2005;
Willis and Borok 2007). Repression of E-cadherin
expression is a key step in the EMT process (Burdsal
et al. 1991). Growth factor signalling pathways have
been shown to modulate activity of transcription
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factors that repress E-cadherin gene expression
(Thiery 2003). SNAI1, SNAI2, ZEB1, ZEB2 and
Twist are transcriptional repressors of E-cadherin and
other epithelial genes (Peinado et al. 2007). Several of
these factors also induce expression of mesenchymal
genes and so are regarded as the molecular effectors of
EMT. SNAI1 is downstream of TGF-b1 and FGF
signalling pathways (Thiery 2003; Zavadil and
Bottinger 2005) and regulates induction of EMT in
response to these growth factors.
Bone morphogenetic proteins (BMPs) form a
highly conserved group within the transforming
growth factor b (TGF-b) superfamily of secreted
growth factors. To date, more than 20 BMPs have
been described (Chen et al. 2004). During develop-
ment, BMPs regulate a variety of processes including
left-right asymmetry, mesodermal patterning and
organogenesis (Herpin and Cunningham 2007). In
the adult, the role of BMPs in bone formation has
been widely investigated. BMPs are also involved in
proliferation, differentiation, apoptosis and regener-
ation processes in other adult tissues (Simic and
Vukicevic 2005; Abe 2006).
BMP2 and BMP4 are 92% identical (Wozney 1992)
and are the mammalian homologues of Drosophila
decapentaplegic peptide (Dpp) (Wozney 1989). Both
are critical to a variety of developmental processes
including EMTaspects of morphogenesis (Chen et al.
2004). BMP4 drives early mesoderm formation
(Winnier et al. 1995) while BMP2 is required for
EMT during heart morphogenesis (Okagawa et al.
2007). Homozygous deletions of BMP2 and BMP4 in
mice are embryonic lethal due to abnormal heart
development and a failure of mesoderm formation,
respectively (Winnier et al. 1995; Zhang and Evans
1996). In the developing lung, BMP4 regulates
branching morphogenesis and modulates proximal-
to-distal differentiation of ciliated and secretory
airway epithelial cells although the mechanism
involved is unknown (Weaver et al. 1999). A role for
BMP2 in lung development has not yet been
established. BMP4 induces EMT during neural crest
formation via upregulation of SNAI2 expression
(Sakai et al. 2006).
BMP signals are transduced via hetero-oligomeric
types I and II receptors (Ruberte et al. 1995; Nohe
et al. 2002). Following ligand binding, BMPR-II
transphosphorylates type I receptors which in turn
recruit and phosphorylate the receptor-regulated
Smads (R-Smads) 1,5 and/or 8 (Attisano and Wrana
2000). Activated R-Smads form heteromeric
complexes with Smad4 which is also involved in
TGF-b and activin signalling pathways. Heteromeric
Smad complexes translocate to the nucleus where they
act as transcriptional co-modulators of specific target
genes. In addition to the canonical Smad signalling
pathway, BMP receptor-mediated signalling also
interacts with p38 mitogen-activated protein kinase,
Toll and Notch signalling pathways (Herpin and
Cunningham 2007). Relatively few BMP target genes
have thus far been identified in mammalian cells
(Frontelo et al. 2004; Miyazono et al. 2005; Perk et al.
2005). Notably with regard to EMT, SNAI1 is one
such target gene (Miyazono et al. 2005).
It has been proposed that signals critical to lung
morphogenesis, such as BMP4, are also likely to be
involved in regeneration and disease processes in adult
lungs (Bellusci et al. 1996; Warburton and Bellusci
2004). BMP2 is overexpressed in human lung
carcinomas (Langenfeld et al. 2005). BMP4 has
been reported to induce senescence in A549 cells
in vitro (Buckley et al. 2004) and BMP pathway
activation and upregulation of BMP4 occurs in
allergen-induced inflammation in mouse lungs in vivo
(Rosendahl et al. 2002). However, despite being
members of the TGF-b superfamily, the role of BMPs
in adult lungs has received little attention to date and
remains unknown. TGF-b has recently been shown to
induce EMT in alveolar epithelial cells in vitro and
in vivo indicating a possible novel mechanism for lung
fibrosis (Willis and Borok 2007). BMP4 induces EMT
in adult ovarian, mammary and pancreatic cancer cells
(Montesano 2007; Hamada et al. 2007; Theriault et al.
2007). In this study, we investigated the effects of
BMP4 on adult airway epithelial cells using the BEAS-
2B cell line. BMP4 inhibited proliferation and
induced epithelial–mesenchymal transition (EMT)-
like changes in BEAS-2B cells. Our study reveals that
aspects of the EMT-inducing activities of BMP4
during development are recapitulated in adult lung
cells and indicates that inappropriate BMP-mediated
EMT in vivo could directly contribute to lung
inflammation and fibrosis.
Materials and methods
Cell culture
BEAS-2B cells were obtained from the American
Type Culture Collection. Cells were routinely cultured
in a 1:1 mixture of DMEM:Hams-F12 medium
supplemented with 5% fetal bovine serum (Gibco,
Glasgow, UK) and 2 mM L-glutamine (Gibco). Cells
were maintained at 378C in a humidified atmosphere of
5% CO2. Experiments were carried out within five
passage numbers of each other.
Treatment of BEAS-2B cells with BMP4
Cellswere harvested at.80% confluency and seeded in
DMEM supplemented with 10% FBS and 2 mM
L-glutamine at densities of 4 £ 103 cells per well of a
24-well tissue culture plate, 5 £ 104 cells per 25 cm2
tissue culture flask or 1.5 £ 105 cells per 75 cm2 flask
depending on the experiment. After overnight attach-
ment, cellswere rinsed three timeswithbasalHams-F12
BMP4 induces EMT-like changes in AECs 13
D
ow
nl
oa
de
d 
B
y:
 [N
at
io
na
l U
ni
ve
rs
ity
 o
f I
re
la
nd
 M
ay
no
ot
h]
 A
t: 
09
:3
4 
27
 M
ar
ch
 2
00
8 
medium and 100 ng/ml BMP4 (R&D Systems, Min-
neapolis, USA) was added in defined serum-free
medium (1:1 Hams-F12:M199 medium supplemented
with 2 mM L-glutamine (Gibco), 100 U/ml penicillin
(Gibco), 100mg/ml streptomycin (Gibco), 100 U/ml
insulin– transferin–selenium (Gibco), 100 ng/ml
hydrocortisone (Sigma–Aldrich, Dublin, Ireland) and
10 ng/ml epidermal growth factor (R&D Systems).
Cell counts
Cell numbers and viability were determined by
ethidium bromide/acridine orange staining and cell
counting using a haemocytometer. Adherent cells and
suspension cells were harvested by trypsinisation and
centrifugation respectively and total viable and non-
viable populations were determined.
Cell motility assay
Cells were grown to confluency on glass coverslips
(25 mm) in six-well tissue culture plates and were
wounded with a sterile 200-ml pipette tip to generate a
cell-free area of approximately 500mm in width. Cell
debris was removed by washing with PBS and cells
were cultured in defined serum-free medium for 24 h.
Medium was replaced with fresh defined serum-free
medium with or without BMP4 (100 ng/ml) in
triplicate wells. At 4, 8 and 17 h, cells were fixed
with methanol for 5 min, air-dried and stained with
crystal violet solution (Sigma). Phase-contrast photo-
micrographs of five fields of view per scrape were
acquired using an inverted microscope equipped with
a digital camera (Olympus C-310). Cells in each field
of view were counted and the average number of cells
present in each scrape with each treatment was
determined.
Immunofluorescence
At appropriate timepoints, cells were rinsed with PBS
and fixed at 2208C for 5 min with pre-chilled
methanol. Phosphorylated Smad1/5/8 antibody
(New England Bio Labs, Beverly, MA, USA) was
incubated overnight at 48C followed by a 30 min at
room temperature incubation with goat anti-rabbit
Alexa Fluorw 488-labelled secondary antibody (Mol-
ecular Probes, Invitrogen, Paisley, UK). Cells were
counterstained using DAPI nuclear stain (Sigma).
Fluorescence was examined using an Olmypus IX81
fluorescent microscope, where camera and micro-
scope settings (exposure time, brightness and light
intensity) were kept constant across treatments
(Olympus Life and Material Science Europe, Ham-
burg, Germany). Cells omitting primary antibody
were included as a control.
Western blotting
Cells were scraped in ice-cold PBS and pellets
were lysed in radioimmunoprecipitation assay
(RIPA) buffer (Sigma). Protein (10mg per lane) was
electrophoresed through 10% polyacrylamide gels
and blotted onto nitrocellulose membrane. Blots
were probed with primary antibodies for either 1 h
at room temperature or overnight at 48C and
incubated with horseradish peroxidase-linked second-
ary antibodies for 1 h at room temperature. Visualisa-
tion was performed using an ECL detection system
(Amersham, Little Chalfont, UK). Antibodies
were E-cadherin (clone-36), a-catenin (clone-5),
b-catenin (clone-14) and g-catenin (clone-15)
(Becton–Dickinson), cytokeratin 8 (clone M20)
(Sigma) and cytokeratin 18 (Clone CY-90) (Sigma).
Quantification was carried out by comparative
densitometry with actin (20-33) (Sigma) using
QuantityOnew software version 4.4.1 (Bio-Rad
Laboratories Inc., Hertfordshire, UK).
Semi-quantitative PCR
Total RNA was isolated using TRIZOL Reagent
(Invitrogen). After quantity/quality confirmation, 1mg
was DNase treated (Sigma) and reverse transcribed
with 200 U SuperScripte III (Invitrogen). PCR
products were visualised on ethidium bromide stained
gels and semi-quantified using the QuantityOne
software version 4.4.1 (Bio-Rad). Values obtained
were normalised using housekeeping gene, glyceral-
dehyde-3-phosphate (GAPDH). Target transcripts
were amplified using 300 nM primer (note: two
independent primer sets were used for COL1A1,
COL1A2 and Vimentin) (Table I).
PCR arrays
For PCR array experiments, total RNA was isolated
from BEAS-2B cells using RNeasye and QIAshred-
der columns (QIAGEN Ltd., West Sussex, UK)
according to manufacturer’s directions and included
the on-column DNase digestion step. RNA quantity
and quality was confirmed both by ethidium bromide
(Sigma) staining for ribosomal RNA band integrity
and UV–Vis spectrophotometry. Only high quality
RNA (A260:A280 and A260:A230 ratios greater than
2.0) was used.
RT2 Profilere PCR arrays for housekeeping genes
and ECM-related genes, cDNA synthesis reagents
and RT2 SYBRe green PCR master mixes were all
purchased from SuperArray Bioscience Corporation
(Maryland, USA) and protocols were followed
precisely. In brief, for first strand cDNA synthesis,
1mg total RNA was incubated with random hexamers
and oligodT primers at 708C for 3 min, then at 378C
for 10 min to permit annealing. An equal volume of RT
E. L. Molloy et al.14
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mix was then added, incubated at 378C for 1 h and
then heated to 958C for 5 min. The cDNA was then
diluted with 4 vol of ddH2O to a final volume of
100ml. Ninety-eight microlitres of this was combined
with 2X SYBRaˆ green PCR master mix and ddH20,
then aliquoted to the PCR array. No RT and no
template controls were included on all plates. PCR
was performed on a DNA Engine Opticonw (Bio-
Rad). After an initial 10 min heat step at 958C, 40
cycles of: 15 s at 958C, 40 s at 558C and 30 s at 728C
were performed.
Data were exported to Microsoft Excel and
fold changes in gene expression were calculated by
the 2 (2DDCt) method. Average cycle threshold (Ct)
was calculated across biological replicates (n ¼ 3,
independent passages) for each gene and the DCt was
calculated by subtraction of the average Ct of five
housekeeping genes.
Quantitative PCR
Total RNA was isolated using TRIZOL Reagent
(Invitrogen). After quantity/quality conformation,
1mg was DNase treated (Sigma) and reverse
transcribed with 200 U SuperScripte III (Invitrogen).
QPCR was performed using the Quantitectaˆ SYBRaˆ
Green mastermix (Qiagen) and Quantitectaˆ primer
assays (Qiagen) were used for GAPDH, COL5A1,
TGFBI, MMP2 and ZEB2. CDH1 primers were
designed in house [sense: 50-TCTGATTCTGCTG-
CTCTTGC-30 and antisense 50-AAAGTCCTGGT-
CCTCTTCTCC-30] and used at 300 nM each. All
assays were performed on the DNA Engine Opticonw
and relative quantitation was computed from a 4–5
log range standard curve generated from 1:10 serial
dilutions of cDNA. Samples (n ¼ 3) were run in
triplicate and GAPDH was used as the endogenous
control.
Results
BMP pathway activation in BEAS-2B cells in response
to BMP4
To determine whether BEAS-2B cells contain a BMP
signalling pathway, the expression, activation and
localisation of Smad proteins was examined.
The P-Smad antibody used here cross-reacts with
the phosphorylated forms of Smads 1, 5 and 8. Smad
1/5/8 phosphorylation was detected in BEAS-2B cells
cultured in control defined serum-free medium
without BMP4 treatment at both the 20 min and day
6 time points indicating a basal level of pathway
activity in these cells (Figure 1). Following stimulation
with BMP4, an increase in levels of phosphorylated
Smad 1/5/8 was evident by immunofluorescence and
Western blotting (Figure 1). An increase in nuclear
localisation of phosphorylated Smad 1/5/8 was also
apparent (Figure 1a). Thus, BEAS-2B cells are
capable of responding to BMP4 ligands and increased
pathway activity is maintained for at least 6 days
following introduction of ligand.
BMP4 induces a fibroblast-like morphology in BEAS-2B
cells
The BEAS-2B cell line was originally derived from
normal bronchial epithelium (Reddel et al. 1988).
Cells were routinely cultured in the presence of fetal
bovine serum. Cells transferred to control defined
serum-free medium for up to 10 days retained
characteristic epithelial cell morphologies (Figure 2a,
c, e). In contrast, after 3 days of culture in defined
serum-free medium containing 100 ng/ml BMP4, an
alteration in BEAS-2B cell morphology was apparent
in areas where colonies had formed (Figure 2b).
In these areas, cells appeared more elongated and
angular and had reduced cell–cell contacts compared
Table I. RT-PCR primer sets.
Primer Sense Antisense
SNAI1 50-CCAGAGTTTACCTTCCAGCA-30 50-CAGAGTCCCAGATGAGCATT-30
SNAI2 50-CCTGGTCAAGAAGCATTTCA-30 50-CCTTGGAGGAGGTGTCAGAT-30
SNAI3 50-ACACAGGGGAGAAGCCCTAT-30 50-ACATGCGGGAGAAGGTCT-30
ZEB1 50-CACCCTTGAAAGTGATCCAG-30 50-TCTTCCGCATTTTCTTTTTG-30
Twist 50-CTTCTCGGTCTGGAGGATG-30 50-TCCATTTTCTCCTTCTCTGG-30
Desmin 50-AACCTTCTCTGCCCTCAACT-30 50-GATCATCACCGTCTTCTTGG-30
N-cadherin 50-TGTTTTGGACCGAGAATCAC-30 50-TAACACTTGAGGGGCATTGT-30
Set 1 COL1A1 50-CTGGTGCTAAAGGTGCCAAT-30 50-CTCCTCGCTTTCCTTCCTCT-30
Set 2 COL1A1 50-GTGCTACTGGTTTCCCTGGT-30 50-ACCTTTGCCACCTTCTTTG-30
Set 1 COL1A2 50-GAAAACATCCCAGCCAAGAA-30 50-GCCAGTCTCCTCATCCATGT-30
Set 2 COL1A2 50-CCGAACTGGAGAAGTAGGTG-30 50-AGGGAGACCCAGAATACCAG-30
Fibronectin 50-GGAAAAGGAGAATGGACCTG-30 50-CTTCTCCCAGGCAAGTACAA-30
Set 1 vimentin 50-CGAAAACACCCTGCAATCTT-30 50-GTGAGGTCAGGCTTGGAAAC-30
Set 2 vimentin 50-AACCTGACCGAGGACATCATG-30 50-TTCTCGGCTTCCTCTCTCTGAA-30
a-SMA 50-ACTACTGCCGAGCGTGAGAT-30 50-ATAGGTGGTTTCGTGGATGC-30
Keratin 18 50-GGAGCACTTGGAGAAGAAGG-30 50-GGGCATTGTCCACAGTATTT-30
GAPDH 50-CTGCACCACCAACTGCTTAG-30 50-CCAGGAAATGAGCTTGACAAA-30
BMP4 induces EMT-like changes in AECs 15
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Figure 1. BMP4 activates BMP pathway in BEAS-2B cells. (a) Representative photomicrographs of phosphorylated-Smad1/5/8 in cells
stimulated with BMP4 for 20 min and 6 days. Initial 20 min stimulus resulted in increased levels of phosphorylated-Smad1/5/8. After 6 days of
culture, increased levels appeared sustained in BMP4-treated cells. Arrows indicate increased expression levels and/or nuclear translocation.
Scale bars represent 50mm. (b) Western blot analysis and corresponding densitometry quantification confirmed increased p-Smad levels in
BMP4-treated cells. Bars represent the mean ^ SEM of three independent experiments. Students t test was used to determine significance,
**P , 0.001.
+ BMP4
Day 6
Day 10
Untreated
+ BMP4 – BMP4
Day 3
(e) (f)
(c) (d)
(a) (b)
(g)
Figure 2. BMP4 induces a mesenchymal-like change in morphology. Phase contrast photomicrographs of BEAS-2B cells grown in serum-
free medium (untreated) or in serum-free medium containing 100 ng/ml BMP4 (þ BMP4) for 3 days (a and b) or 6 days (c and d). At day 3, a
change in morphology is apparent in the presence of BMP4 (b). At day 6, untreated cells display typical epithelial cell morphology (c).
In contrast, BMP4-treated cells appear more fibroblast-like with loss of cell–cell contact (d). At day 6, cells were either left untreated or media
was removed and replaced with either serum-free medium (2BMP) or serum-free media containing BMP4 ( þ BMP4). Phase contrast
images were obtained 4 days later. Untreated cells at day 10 retained an epithelial-like morphology (e). BMP4-treated cells which were
re-stimulated at day 6 displayed an enhanced fibroblast-like morphology (f). Cells which had BMP4 withdrawn retained their fibroblast-like
morphology (g) and appeared similar to their day 6 counterparts (d).
E. L. Molloy et al.16
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to untreated cells. By day 6, BMP4-treated cell
exhibited a spindle-shaped, fibroblast-like mor-
phology (Figure 2d). When cells were re-fed with
BMP4-containing medium at day 6, the morphologi-
cal effect was even more pronounced 4 days later at
day 10 (Figure 2f). When BMP4-containing medium
was replaced at day 6 with BMP4-free defined serum-
free medium, the fibroblast morphology was still
apparent at day 10 (Figure 2g). This indicates that the
morphological effect is not ‘scattering’ which is
normally reversed upon removal of the scatter-
inducing factor (Janda et al. 2002).
Effects of BMP4 on proliferation and motility
Given the marked effect of BMP4 on BEAS-2B cell
morphology, we next examined proliferation and
motility effects. After 6 days of culture, BMP4-induced
a 48% decrease in BEAS-2B cell number compared to
control medium (Figure 3a). The reduction in cell
number was not due to BMP4-induced toxicity as an
average of 5.7 and 4.1% non-viable cells were present
in control and BMP4-stimulated populations, respect-
ively (n ¼ 3, data not shown).
A scrape assay was carried out to analyse BEAS-2B
cell motility in a wounded monolayer in response to
BMP4. Over a period of 17 h, the wounded area
remained largely unchanged in untreated monolayers
(Figure 3b and c). In contrast, in the same period, cells
cultured in the presence of BMP4 migrated to refill the
wounded area. It is unlikely that the area was
repopulated by proliferating cells rather than migrating
cells as proliferation was reduced in BMP4-treated
cells compared to untreated controls (Figure 3a).
BMP4 alters expression of adherens junction proteins
in BEAS-2B cells
Because morphology and motility were altered in
BEAS-2B cells cultured with BMP4, we next
investigated expression of epithelial-related adherens
junction proteins and cytoskeletal proteins in BMP4-
treated cells. The expression of E-cadherin, a-, b- and
g-catenin and cytokeratins 8 and 18 was examined.
E-cadherin expression was almost completely abol-
ished and was barely detectable by Western blot in
BEAS-2B cells cultured with BMP4 (Figure 4).
Expression of b- and g-catenin was also significantly
reduced in response to BMP4. No change in expression
levels of a-catenin, cytokeratin 8 or 18 was detected in
cells cultured with BMP4 at this time point.
Expression of transcriptional regulators in BMP4-treated
cells
The morphological and phenotypic changes observed
in BEAS-2B cells in response to BMP4 resemble an
EMT. We therefore examined the expression of several
0
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Figure 3. BMP4 modulates BEAS-2B cell proliferation and migration. (a) BMP4 significantly inhibited cell proliferation at day 6.
Proliferation is presented as fold relative to the seeding density. Each bar represents the mean ^ SEM of three independent experiments.
Significance as compared to untreated cells was obtained using the students t test, **P , 0.001. (b) A wound assay was performed to assess the
effect of BMP4 on cell migration. Cells in the presence of BMP4 began to migrate after 4 hr and at 17 h the wounded area was entirely
repopulated. (c) Graph illustrates number of cells migrated at each time point. Bars represent the mean ^ SEM of three independent
experiments. Students t-test was used to determine significance, where ***P , 0.0001.
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transcriptional regulators which are known to either
downregulate epithelial gene expression, induce
mesenchymal gene expression, or both during EMT.
The expression of Snai1, Snai2, Snai3, Zeb1, Zeb2 and
Twist was consistently increased in BMP4-treated
BEAS-2B cells at the day 6 time point (Figure 5).
Altered expression of mesenchymal markers in response
to BMP4
The expression of several mesenchymal markers
typically expressed in EMT was examined by semi-
quantitative PCR in BMP4-treated cells. Desmin and
N-cadherin gene expression was significantly
increased in BEAS-2B cells in response to BMP4
(Figure 6). Expression of collagen 1A1 and 1A2,
fibronectin and vimentin was also consistently
increased while a-smooth muscle actin appeared
unchanged at day 6. Cytokeratin 18 expression was
not changed at the mRNA level with BMP4 treatment.
BMP4 modulates expression of extracellular matrix-
related genes in BEAS-2B cells
To gain further insight into the phenotype-induced by
BMP4 treatment of BEAS-2B cells, PCR array plates
were used to quantitatively analyse expression of a wide
range of extracellular matrix (ECM)-related genes.
From a total of 84 ECM-related genes examined in
BMP4-treated BEAS-2B cells, significant increases in
expression of 13 genes (Table II) and significant
decreases in expression of 12 genes (Table III) were
detected. No significant changes were detected in
expression levels of the remaining genes (Supplemen-
tary Table I). Cell adhesion molecules, ECM proteins
and ECM-degrading enzymes were represented in
both the upregulated and downregulated cohorts of
genes. Expression of genes encoding tenascin C,
tetranectin, thrombospondin 2, matrix metalloprotei-
nase (MMP) 16 and vascular cell adhesion molecule
(VCAM) were increased more than 5-fold. In contrast,
E-cadherin, collagen VIa1 and gelatinase A gene
expression was reduced more than 6-fold.
Four genes from the PCR arrays were selected
for verification by independent QPCR. CDH1
(E-cadherin) and MMP2 (gelatinase A) were selected
as the two genes with the largest reduction in expression
levels. COL5A1 (collagen Va1) and TGFBI (TGF-b-
induced) were selected as genes with relatively modest
increased levels of expression. QPCR was done using
total RNA newly isolated from three independent
passages of BEAS-2B cells and using alternative primers
to those used in array experiments. Similar changes in
gene expression were detected when COL5A1, TGFBI
andCDH1were examined by QPCR compared with the
PCR arrays (Figure 7). While, a reduction in MMP2
expression was detected using QPCR, the extent of the
reduction was less that that observed using PCR arrays.
Discussion
BMPs possess a wide range of biological activities
that influence processes such as morphogenesis,
proliferation, apoptosis and differentiation in several
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Figure 4. Expression of adherens junction proteins and cytokeratin proteins in BMP4-treated cells. (a) Western blot images of adherens
junction and cytokeratin protein expression in untreated cells and cells cultured with BMP4 ( þ BMP4) for 6 days. (b) Densitometric
quantification presented as fold change compared to untreated cells. BMP4 treatment resulted in decreased expression of adherens proteins.
No change in cytokeratin expression was detected. Values were normalised to actin. Each bar represents the mean ^ SEM of at least three
independent experiments. Significance compared to untreated cells was obtained using the students ttest (*P , 0.05 and ***P , 0.001).
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cell types both during development and in adult
tissues (Chen et al. 2004). BMP4 is essential during
lung morphogenesis and regulates differentiation of
airway epithelial cells within the developing lung bud
(Bellusci et al. 1996). However, little is known
regarding the role of BMPs in adult lungs. It has
previously been reported that BMP4 induces senes-
cence in A549 cells in vitro (Buckley et al. 2004).
We found no evidence of senescence in BEAS-2B cells
in response to BMP4 (data contained in Supplement).
In the present study, we have demonstrated that
BMP4 modulates proliferation, morphology and cell
adhesion in BEAS-2B human bronchial epithelial cells
in a manner consistent with EMT. BMP pathway
activation and upregulation of BMP4 expression has
been reported in allergen-induced inflammation in
mouse lungs (Rosendahl et al. 2002). Our findings
indicate that the role of BMP4 as a morphogen and
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Figure 5. BMP4 modulates expression of transcription factors involved in EMT. (a) RT-PCR analysis demonstrates upregulation of several
transcriptional regulators of E-cadherin gene expression at day 6 after BMP4 treatment. (b) Densitometric quantification was carried out and
normalised to glyceraldehyde-3-phosphate (GAPDH). Real Time PCR data is presented for Zeb2. Data presented as fold change compared to
untreated cells where bars represent the mean ^ SEM of three independent experiments. While genes were consistently upregulated
following BMP4 treatment, no significance was obtained using the student’s t-test.
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Figure 6. BMP4 modulates expression of cytoskeletal and ECM-related genes. (a) RT-PCR analysis of cytoskeletal and ECM-related gene
expression following treatment with BMP4. (b) Densitometric quantification was carried out and normalised to glyceraldehyde-3-phosphate
(GAPDH). Data presented as fold change compared to control where bars represent the mean ^ SEM of three independent experiments.
Significance compared to untreated cells was obtained using the student’s t-test (*P , 0.05).
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inducer of EMT during development may be
recapitulated in adult lungs during inflammatory and
disease processes.
The detection of phosphorylated Smad 1/5/8 in
BEAS-2B cells cultured in control defined serum-free
medium for 6 days indicates autocrine BMP activity in
these cells. We have confirmed that BEAS-2B cells
express BMP4 mRNA as well as that of BMP2 and
BMP7 (data not shown). Increased levels of phosphory-
lated Smads following addition of BMP4 indicates that
the cells can respond specifically to this ligand.
Under the present conditions where cells were seeded
at low densities, the induction of a mesenchymal-like
morphology in BEAS-2B cells occurred 3 days after
addition of BMP4. It was noted that the morphological
change usually occurred only after cells had established
cell–cell contact and formed colonies. The retention of
this mesenchymal-like morphology following the
removal of BMP4 indicates that the effect is not merely
a scatter effect, which would be expected to revert upon
removal of BMP4, but rather a more permanent change
in cell phenotype consistent with an EMT. BMP4-
treated BEAS-2B cells also exhibited reduced prolifer-
ation and increased motility, both of which are also
features of EMT.
The appearance of the fibroblast-like morphology
and increased motility were associated with changes in
expression of epithelial and mesenchymal markers.
BMP4 induced almost complete abrogation of
E-cadherin protein expression in BEAS-2B cells
(Figure 4). The downregulation of E-cadherin protein
expression was reflected at the mRNA level both in the
PCR array study (Table III) and by QPCR (Figure 7).
Functional loss of E-cadherin is a hallmark of EMT
during both development and tumour progression
(Larue and Bellacosa 2005). Upregulation of Snai1,
Snai2 and other transcriptional repressors in BEAS-
2B cells following BMP4 treatment indicates that
similar activation of EMT-related signalling pathways
occurs in adult lung cells in response to BMPs.
Reduced E-cadherin expression was accompanied by
significant downregulation of b- and g-catenin protein
Table II. Extracellular matrix-related genes upregulated by BMP4.
Accession ID Gene name Symbol P value BMP4/untreated
NM_001078 Vascular cell adhesion molecule 1 VCAM1 0.0014 13.48
NM_003247 Thrombospondin 2 THBS2 0.0001 9.17
NM_003278 C-type lectin domain family 3, member B (tetranectin) CLEC3B 0.0007 8.82
NM_005941 Matrix metallopeptidase 16 (membrane-inserted) MMP16 0.0000 7.05
NM_002160 Tenascin C (hexabrachion) TNC 0.0015 5.51
NM_001855 Collagen, type XV, alpha 1 COL15A1 0.0311 4.43
NM_002026 Fibronectin 1 FN1 0.0041 3.70
NM_021110 Collagen, type XIV, alpha 1 COL14A1 0.0010 3.10
NM_000093 Collagen, type V, alpha 1 COL5A1 0.0002 2.34
NM_000358 Transforming growth factor, beta-induced, 68 kDa TGFBI 0.0266 2.32
NM_000211 Integrin, beta 2 ITGB2 0.0045 2.02
NM_002423 Matrix metallopeptidase 7 (matrilysin) MMP7 0.0013 1.54
NM_004370 Collagen, type XII, alpha 1 COL12A1 0.0410 1.53
Mean expression (Ct) values were calculated from n ¼ 3 arrays and fold difference between BMP4 and untreated cells was calculated as
2DDCt. Fold changes less than 1 are expressed as the negative inverse. P values were calculated by Student’s paired t-test with a two-tailed
distribution and significance established at P , 0.05.
Table III. Extracellular matrix-related genes downregulated by BMP4.
Accession ID Gene name Symbol P value BMP4/untreated
NM_004530 Matrix metallopeptidase 2 (gelatinase A) MMP2 0.0001 231.96
NM_004360 Cadherin 1, type 1, E-cadherin CDH1 0.0001 215.15
NM_001848 Collagen, type VI, alpha 1 COL6A1 0.0011 26.45
NM_001523 Hyaluronan synthase 1 HAS1 0.0019 24.77
NM_007037 ADAM metallopeptidase w/thrombospondin type 1 motif, 8 ADAMTS8 0.0002 24.12
NM_001331 Catenin (cadherin-associated protein), delta 1 CTNND1 0.0458 23.20
NM_001849 Collagen, type VI, alpha 2 COL6A2 0.0116 22.42
NM_002291 Laminin, beta 1 LAMB1 0.0128 22.15
NM_139028 ADAM metallopeptidase w/thrombospondin type 1 motif, 13 ADAMTS13 0.0128 22.12
NM_001850 Collagen, type VIII, alpha 1 COL8A1 0.0146 22.06
NM_003255 TIMP metallopeptidase inhibitor 2 TIMP2 0.0129 21.61
NM_003119 Spastic paraplegia 7 SPG7 0.0470 21.56
Mean expression (Ct) values were calculated from n ¼ 3 arrays and fold difference between BMP4 and untreated cells was calculated as
2DDCt. Fold changes less than 1 are expressed as the negative inverse. P values were calculated by Student’s paired t-test with a two-tailed
distribution and significance established at P , 0.05.
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levels. Expression of these genes remained unchanged
in the PCR array study (Supplementary Table I),
however, suggesting possible post-translational regu-
lation of these proteins in response to BMP4.
At the day 6 time point examined in this study,
alterations in expression of several mesenchymal
markers associated withEMTwere apparent in response
to BMP4. Desmin and N-cadherin mRNA levels were
significantly upregulated while collagens, fibronectin
and vimentin were also consistently increased. A
broader view of the phenotypic changes induced by
BMP4 was obtained in the PCR array study which
revealed changes in expression of genes encoding several
ECM proteins and matrix degradingenzymes. In several
cases, the identity of these genes and the directionality of
their change were consistent with EMT. For example,
increased expression of thrombospondin 2, tenascin C,
fibronectin, MMP7, integrin b2 and collagen genes has
been reported in EMT, during either development or
tumour progression, and sometimes both (Chagraoui
et al. 2003; Maschler et al. 2004; Larue and Bellacosa
2005). Similarly, downregulation of E-cadherin and
d-catenin gene expression seen from the PCR array
(Table II) is consistent with EMT. However, several
genes that were downregulated by BMP4 such as
MMP2 and other matrix degrading enzymes, have
previously been reported as upregulated during EMT
(Larue and Bellacosa 2005). In addition, levels of
cytokeratin 8 and 18 proteins would be expected to
decline during EMT but were unchanged with BMP
treatment. The process of EMT is not well defined in
adult cells and it is unknown what, if any, gene
expression profile represents this process. It is likely that
this profile varies with cell type, microenvironment and
specific time point within the EMT process. For
example, during development, MMP2 is expressed
while neural crest cells undergo EMT but is rapidly
downregulated as they disperse (Duong and Erickson
2004). It is possible that different concentrations of
BMP4, the presence of additional signals, or a longer
exposure time would result in further EMT-related
changes in BEAS-2B cells. Alternatively, the extent to
which epithelial features are lost, and mesenchymal
characteristics are acquired, varies during both devel-
opmental- and carcinogenesis-associated EMT,
depending on cell type (Shook and Keller 2003).
Therefore, complete lossof epithelial markersmay never
occur in BEAS-2B cells, regardless of signals
encountered.
This study represents the first report of EMT-like
changes in airway epithelial cells. EMT has been
demonstrated in alveolar epithelial cells, both primary
cells and cell lines, in response to TGF-b (Willis and
Borok 2007). It has been suggested that EMTof alveolar
cells may contribute to fibrosis in vivo in diseases such as
idiopathic pulmonary fibrosis. Although it is not known
if BMPs are involved in EMT during lung morphogen-
esis, they are known to play a key role in EMT in other
developing and adult tissue types. Our study indicates
that this activity may be recapitulated in adult airways,
possibly during inflammatory and remodelling
processes in airway diseases such as asthma. Reduced
E-cadherin expression alone could compromise epi-
thelial barrier integrity and contribute to inflammation.
Full EMT could result in increased numbers of
fibroblasts in the airways and loss of epithelial functions.
BMP-mediated EMT may thus be a mechanism for
fibrosis in inflammatory airway diseases.
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